MET and metastatic malignant neoplasm in the lymph nodes: Our study also shows for the first time that co-expression of MET and CD47 in luminal-type primary tumors represents an even better independent predictor for reduced overall-survival compared to expression of MET or CD47 alone and that it strongly correlates with lymph node metastasis.